首页> 外国专利> Pharmaceutical composition for treating CNS injury-related diseases comprising CCL2 or CCL2 agonist

Pharmaceutical composition for treating CNS injury-related diseases comprising CCL2 or CCL2 agonist

机译:包含CCL2或CCL2激动剂的用于治疗CNS损伤相关疾病的药物组合物

摘要

The present invention relates to a pharmaceutical composition for treating a central nervous system damage-related disease comprising as an active ingredient CCL2 or CCL2 agonist, wherein said CCL2 mediates neuron-macrophage interactions to regulate axonal regeneration caused by conditioning damage (CI) Therefore, it is possible to effectively treat central nervous system damage diseases such as stroke or spinal cord injury, and to screen drugs for treating central nervous system injury-related diseases by selecting candidate drugs that promote CCL2 expression or activity.
机译:本发明涉及用于治疗中枢神经系统损伤相关疾病的药物组合物,其包含CCL2或CCL2激动剂作为活性成分,其中所述CCL2介导神经元-巨噬细胞相互作用以调节由条件性损伤(CI)引起的轴突再生。通过选择促进CCL2表达或活性的候选药物,可以有效治疗中风或脊髓损伤等中枢神经系统损伤疾病,并筛选用于治疗中枢神经系统损伤相关疾病的药物。

著录项

  • 公开/公告号KR101723267B1

    专利类型

  • 公开/公告日2017-04-07

    原文格式PDF

  • 申请/专利权人 아주대학교산학협력단;

    申请/专利号KR20140119233

  • 发明设计人 김병곤;권민정;

    申请日2014-09-05

  • 分类号G01N33/68;A61K38;A61K39/395;G01N33/53;

  • 国家 KR

  • 入库时间 2022-08-21 13:25:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号